GSK3β inhibitor II

Cat. No.: OB0225WX-2161

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: GSK3β inhibitor II functions as a molecular antagonist of glycogen synthase kinase-3 beta, characterized by its inhibitory action on this specific kinase isoform.

Synonym: 478482-75-6; GSK-3 Inhibitor II; GSK-3beta Inhibitor II; GSK3|A Inhibitor II; GSK3beta Inhibitor II; 2-Thio(3-iodobenzyl)-5-(1-pyridyl)-[1,3,4]-oxadiazole; 2-[(3-iodophenyl)methylsulfanyl]-5-pyridin-4-yl-1,3,4-oxadiazole; 2-((3-Iodobenzyl)thio)-5-(pyridin-4-yl)-1,3,4-oxadiazole; GSK-3b inhibitor II; Pyridine, 4-[5-[[(3-iodophenyl)methyl]thio]-1,3,4-oxadiazol-2-yl]-; 2-[(3-iodophenyl)methylsulfanyl]-5-(4-pyridyl)-1,3,4-oxadiazole; 2-{[(3-iodophenyl)methyl]sulfanyl}-5-(pyridin-4-yl)-1,3,4-oxadiazole; 4-(5-{[(3-iodophenyl)methyl]sulfanyl}-1,3,4-oxadiazol-2-yl)pyridine

CAS No.: 478482-75-6

Compound CID: 6539732

Formula: C₁₄H₁₀IN₃OS

Formula Weight: 395.22

Specification

Relative Density: 1.79 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: GSK3 beta inhibitor II is utilized in cell signaling research as a potent inhibitor to study the specific involvement of GSK-3 beta in the regulation of the epithelial-mesenchymal transition (EMT).